Pfizer Inc. said Friday that initial study results show its experimental antiviral pill for COVID-19 cut rates of hospitalization and death by nearly 90%. Source

JOIN NCOV.LINK NEWSLETTER

And get notified everytime we publish a new Important announcements. We will not email you often, unless there are important things that need to get in touch with you, such as added new tools or new domain names.